Free Trial
NASDAQ:ATHE

Alterity Therapeutics (ATHE) Stock Price, News & Analysis

Alterity Therapeutics logo
$4.54 +0.08 (+1.68%)
As of 11:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Alterity Therapeutics Stock (NASDAQ:ATHE)

Key Stats

Today's Range
$4.33
$4.76
50-Day Range
$3.79
$4.84
52-Week Range
$1.00
$5.87
Volume
3,865 shs
Average Volume
146,715 shs
Market Capitalization
$40.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Moderate Buy

Company Overview

Alterity Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

ATHE MarketRank™: 

Alterity Therapeutics scored higher than 43% of companies evaluated by MarketBeat, and ranked 659th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alterity Therapeutics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Alterity Therapeutics has received no research coverage in the past 90 days.

  • Read more about Alterity Therapeutics' stock forecast and price target.
  • Percentage of Shares Shorted

    0.89% of the float of Alterity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Alterity Therapeutics has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alterity Therapeutics has recently increased by 10.36%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Alterity Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Alterity Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.89% of the float of Alterity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Alterity Therapeutics has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alterity Therapeutics has recently increased by 10.36%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Alterity Therapeutics has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Alterity Therapeutics this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Alterity Therapeutics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alterity Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    38.80% of the stock of Alterity Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.14% of the stock of Alterity Therapeutics is held by institutions.

  • Read more about Alterity Therapeutics' insider trading history.
Receive ATHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATHE Stock News Headlines

Alterity Therapeutics highlighted at MSA Congress
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

ATHE Stock Analysis - Frequently Asked Questions

Alterity Therapeutics' stock was trading at $3.31 at the beginning of the year. Since then, ATHE shares have increased by 37.3% and is now trading at $4.5450.

Alterity Therapeutics's stock reverse split before market open on Monday, January 9th 2023.The 1-10 reverse split was announced on Monday, January 9th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of ATHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alterity Therapeutics investors own include NVIDIA (NVDA), GE Aerospace (GE), Broadcom (AVGO), Meta Platforms (META), Dorian LPG (LPG), CymaBay Therapeutics (CBAY) and

Company Calendar

Today
7/16/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATHE
CIK
1131343
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$12.00
Potential Upside/Downside
+168.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.84
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.04 per share
Price / Book
4.30

Miscellaneous

Outstanding Shares
8,870,000
Free Float
5,427,000
Market Cap
$39.65 million
Optionable
Not Optionable
Beta
0.71
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ATHE) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners